Cannabis Social Equity Programs and Their Unintended Consequences.

Hill B.; Sarkar P.; Hill K. · Cannabis and cannabinoid research · 2026

**Background & Methods** This is a narrative review examining cannabis social equity programs implemented across U.S. jurisdictions and their intersection with public health outcomes. The authors synthesize evidence on legalization impacts, retail licensing patterns, and health disparities in communities targeted by social equity frameworks. **Key Findings** - Cannabis social equity programs, while addressing historical prohibition disparities, have coincided with increased availability of high-potency cannabis products and documented rises in frequent cannabis use and cannabis use disorder (CUD) following legalization in multiple jurisdictions. - Social equity licensing frameworks disproportionately concentrate cannabis retailers in economically underdeveloped neighborhoods that already experience elevated law enforcement cannabis-related activity, limited behavioral health infrastructure, and structural disadvantages. - Communities with increased cannabis retail density and limited access to addiction and psychiatric services demonstrate elevated risk for undertreated CUD and psychiatric symptoms, suggesting a mismatch between cannabis availability expansion and mental health resource capacity. **Dosage & Administration** Not reported. **Safety & Adverse Effects** The review identifies elevated risk for cannabis use disorder and psychiatric symptoms as primary adverse outcomes, particularly in communities with high retail density and limited treatment access. Increased exposure to high-potency cannabis products is associated with greater frequency of use and severity of use-related disorders. **Evidence Quality** This is a narrative review with inherent limitations in study design hierarchy. The authors acknowledge emerging concerns rather than presenting definitive causal evidence. The review synthesizes findings from "several jurisdictions" but does not provide systematic meta-analysis or quantitative synthesis of effect sizes. The conclusions reflect correlational observations and potential mechanisms rather than rigorous experimental evidence. As a review article, this work provides clinical perspective and policy synthesis rather than original data. The authors appropriately position findings as identifying areas requiring clinical attention and further investigation, noting clinicians' role in screening and advocacy rather than presenting conclusive epidemiologic proof of causal mechanisms.

More recent cannabis research